133 related articles for article (PubMed ID: 2018366)
1. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
Lewensohn R; Ehrsson H; Hansson J; Ringborg U
Anticancer Res; 1991; 11(1):321-4. PubMed ID: 2018366
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
[TBL] [Abstract][Full Text] [Related]
3. Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.
Lewensohn R; Hansson J; Ringborg U; Ehrsson H
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):783-8. PubMed ID: 3653195
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
Larsson R; Dhar S; Ehrsson H; Nygren P; Lewensohn R
Br J Cancer; 1998 Aug; 78(3):328-35. PubMed ID: 9703278
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of peptide bound m-L-sarcolysin (peptichemio) on melphalan resistant human myeloma cells in vitro.
Lewensohn R; Fernberg JO; Ehrsson H; Merlini G
Med Oncol Tumor Pharmacother; 1991; 8(4):265-9. PubMed ID: 1820493
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of peptichemio compared to melphalan and meta-DL-sarcolysin.
Morasca L; Erba E
Eur J Cancer (1965); 1980 Aug; 16(8):1105-9. PubMed ID: 7439225
[No Abstract] [Full Text] [Related]
7. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
8. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2.
Gullbo J; Wallinder C; Tullberg M; Lövborg H; Ehrsson H; Lewensohn R; Nygren P; Luthman K; Larsson R
Mol Cancer Ther; 2003 Dec; 2(12):1331-9. PubMed ID: 14707274
[TBL] [Abstract][Full Text] [Related]
10. The effect of the preparation "Peptichemio" on leukopoiesis and experimental tumours of animals compared with that of sarcolysin and thiophosphamide.
Balitsky KP; Veksler IG; Tsapenko VF; Kavetsky RE
G Ital Chemioter; 1980; 27(1):1-5. PubMed ID: 6793439
[No Abstract] [Full Text] [Related]
11. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
[TBL] [Abstract][Full Text] [Related]
12. Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro.
Ducore JM; McNamara L
Cancer Res; 1986 Mar; 46(3):1068-72. PubMed ID: 3080230
[TBL] [Abstract][Full Text] [Related]
13. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
[TBL] [Abstract][Full Text] [Related]
14. DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.
Ringborg U; Lambert B; Lewensohn R; Turesson I
Eur J Cancer Clin Oncol; 1981 Sep; 17(9):991-6. PubMed ID: 7198989
[No Abstract] [Full Text] [Related]
15. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U; Nilsson B
Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid effect on melphalan cytotoxicity, cell-cycle position, cell size, and [3H]uridine incorporation in one of three human melanoma cell lines.
Benckhuijsen C; Osman AM; Hillebrand MJ; Smets LA
Cancer Res; 1987 Sep; 47(18):4814-20. PubMed ID: 3621177
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
[TBL] [Abstract][Full Text] [Related]
18. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
Brox LW; Gowans B; Belch A
Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
[TBL] [Abstract][Full Text] [Related]
19. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
[TBL] [Abstract][Full Text] [Related]
20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
